Company News in the Life Science Industry

»

Reset 

BOAZ Pharmaceuticals Inc. Celebrates Sales Licence Granted In Record Time

Read more ››
By: Nasdaq / GlobenewsWire - 25 May 2019

MDA Celebrates FDA Approval of Zolgensma for Treatment of Spinal Muscular Atrophy in Pediatric Patients

NEW YORK, May 24, 2019 /PRNewswire/ -- The Muscular Dystrophy Association (MDA) today celebrated the decision by the U.S. Food and Drug Administration (FDA) to grant approval of Zolgensma (onasemnogene abeparvovac-xioi), the first gene therapy for a neuromuscular disease. Zolgensma is a one-time... Read more ››

By: PR Newswire Association LLC. - 25 May 2019

Medtronic Chairman and CEO Omar Ishrak to Speak at Bernstein Strategic Decisions Conference

Read more ››
By: Nasdaq / GlobenewsWire - 24 May 2019
Related companies:  Medtronic Plc

HEXO Corp and Newstrike Brands Ltd. Announce Closing of Arrangement

Read more ››
By: Nasdaq / GlobenewsWire - 24 May 2019

HTG Molecular Diagnostics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: Nasdaq / GlobenewsWire - 24 May 2019
Related companies:  HTG Molecular Diagnostics, Inc.

Myovant Sciences Provides Corporate Updates and Reports Financial Results for Fourth Fiscal Quarter and Full Fiscal Year Ended March 31, 2019

Read more ››
By: Nasdaq / GlobenewsWire - 24 May 2019
Related companies:  Myovant Sciences, Inc.

Alder BioPharmaceuticals® Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: Nasdaq / GlobenewsWire - 24 May 2019
Related companies:  Alder BioPharmaceuticals, Inc.

DBV Technologies Announces Results of its 2019 Ordinary and Extraordinary General Meeting and the Appointment of Viviane Monges to the Board of Directors

Read more ››
By: Nasdaq / GlobenewsWire - 24 May 2019
Related companies:  DBV Technologies S.A.

Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: Nasdaq / GlobenewsWire - 24 May 2019
Related companies:  Apellis Pharmaceuticals, Inc.

Aptose Biosciences Establishes New At-The-Market Facility

Read more ››
By: Nasdaq / GlobenewsWire - 24 May 2019
Related companies:  Aptose Biosciences Inc.

Allergan Announces Updated Presentation Time at the Bernstein Strategic Decisions Conference

DUBLIN, May 24, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that Chairman and CEO Brent Saunders will participate in a fireside chat at the Bernstein 35(th) Annual Strategic Decisions Conference in New York, NY. The presentation will begin at 4:00 p.m. Eastern Time on Thursday,... Read more ››

By: PR Newswire Association LLC. - 24 May 2019
Related companies:  Allergan plc

Central Nervous System Diseases Drug Delivery Markets, 2028

DUBLIN, May 24, 2019 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 24 May 2019

Blue Cross Blue Shield of Massachusetts Releases Statement on Trump Administration's Proposed Rollback of Transgender Health Care Accommodations

BOSTON, May 24, 2019 /PRNewswire/ -- In response to the Trump Administration's proposal to eliminate health care protections for transgender people, Andrew Dreyfus, president & CEO of Blue Cross Blue Shield of Massachusetts, released the following statement:

Read more ››
By: PR Newswire Association LLC. - 24 May 2019

Cardiovascular Drug Delivery Markets, 2028

DUBLIN, May 24, 2019 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 24 May 2019

FDA approves first PI3K inhibitor for breast cancer

SILVER SPRING, Md., May 24, 2019 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Piqray (alpelisib) tablets, to be used in combination with the FDA-approved endocrine therapy fulvestrant, to treat postmenopausal women, and men, with hormone receptor (HR)-positive, human... Read more ››

By: PR Newswire Association LLC. - 24 May 2019
Related companies:  U.S. Food and Drug Administration

Global Biomarkers Technologies, Markets, & Competitive Landscape to 2028 Featuring Profiles of 300+ Companies & 471 Collaborations

DUBLIN, May 24, 2019 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 24 May 2019

The Risk of Relapse Increases During the Holidays For Those in Recovery

BRENTWOOD, Tenn., May 24, 2019 /PRNewswire/ -- Ahead of the holiday, American Addiction Centers (NYSE: AAC) reminds people to keep their sober friends in mind during their weekend gatherings. Memorial Day weekend is usually considered the unofficial start of summer with the arrival of sunny,... Read more ››

By: PR Newswire Association LLC. - 24 May 2019

FDA approves Novartis Piqray® - the first and only treatment specifically for patients with a PIK3CA mutation in HR+/HER2- advanced breast cancer

EAST HANOVER, N.J., May 24, 2019 /PRNewswire/ -- Novartis today announced the US Food and Drug Administration (FDA) has approved Piqray(®) (alpelisib, formerly BYL719) in combination with fulvestrant for the treatment of postmenopausal women, and men, with hormone receptor positive, human epidermal... Read more ››

By: PR Newswire Association LLC. - 24 May 2019
Related companies:  Novartis Pharmaceuticals Corporation

Newly Approved Spinal Muscle Atrophy Treatment Zolgensma is Based on Delivery System Discovered by Penn Gene Therapy Pioneer

PHILADELPHIA, May 24, 2019 /PRNewswire/ -- James Wilson, MD, PhD, recalls being struck by the devastating... Read more ››

By: PR Newswire Association LLC. - 24 May 2019

Applied Therapeutics to Present Data at ESC-HF Highlighting AT-001, a Novel, Potent and Selective Aldose Reductase Inhibitor for Treatment of Diabetic Cardiomyopathy

Read more ››
By: Nasdaq / GlobenewsWire - 24 May 2019
Related companies:  Applied Therapeutics Inc.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies